FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark Pharmaceuticals' supplemental application for raloxifene hydrochloride (generic). The drug is indicated for postmenopausal osteoporosis an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer
• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

SUPPL AP for RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)